Representative before the EPO

Company dna zaklady farmaceutyczne polpharma sa
no operation time available
active in Legal Services

We have observed 3 EP applications Miklos Tar has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11733997

PHARMACEUTICAL COMPOSITIONS COMPRISING IMATINIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PROCESSES FOR THE MANUFACTURE THEREOF

IPC classification:
A61K 9/20, A61K 31/506
Agent:
Miklos Tar, Zaklady Farmaceutyczne Polpharma S.A.
Status:
GRANT OF PATENT INTENDED
EP11460067

Novel polymorphic forms of dabigatran etexilate and process for the preparation thereof

IPC classification:
A61K 31/4402, A61P 7/02, C07D 401/12
Agent:
Miklos Tar, Zaklady Farmaceutyczne Polpharma S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813321

Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof

IPC classification:
A61K 9/16, A61K 9/20
Agent:
Miklos Tar, Zaklady Farmaceutyczne Polpharma S.A.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature